This BJ's Wholesale Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
These Are the Stocks With the Largest Changes in Short Interest in July - GS
Cassava Sciences Granted U.S. Patent US 12065440 B2, Application #17/850198 For "SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS", Filed On 6/27/2022
Biggest Stock Movers Today: PANW, FN, and More
Small-cap and Mid-cap Health Care Has Room to Rally - Roth MKM
Insiders Buying Yum China And 2 Other Stocks
Dyne Therapeutics Analyst Ratings
AnaptysBio Analyst Ratings
UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
Morgan Stanley Maintains Overweight on Dyne Therapeutics, Raises Price Target to $52
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Nurix Therapeutics Analyst Ratings
9 Health Care Stocks Whale Activity In Today's Session
Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday?
Perspective Therapeutics Analyst Ratings
ORIC Pharmaceuticals Analyst Ratings
Dyne Therapeutics GAAP EPS of -$0.70 Misses by $0.02
Unveiling 6 Analyst Insights On Kymera Therapeutics
Earnings Summary: Perspective Therapeutics Posts Mixed Q2, Expects Sufficient Funding Till Mid-2026